Evidence map›Paper›PMID 35453381›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Effect of Moderate Consumption of Different Phenolic-Content Beers on the Human Gut Microbiota Composition: A Randomized Crossover Trial.

José Ignacio Martínez-Montoro, Mar Quesada-Molina, Carolina Gutiérrez-Repiso, Patricia Ruiz-Limón, Alba Subiri-Verdugo, Francisco J Tinahones, Isabel Moreno-Indias

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Dietary Phenolic Compounds-Wellbeing and Perspective Applications.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

José Ignacio Martínez-MontoroDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.ORCID 0000-0001-9761-6888
Mar Quesada-MolinaDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.ORCID 0000-0001-8183-7512
Carolina Gutiérrez-RepisoDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.ORCID 0000-0002-5842-8873
Patricia Ruiz-LimónDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.ORCID 0000-0003-3820-428X
Alba Subiri-VerdugoDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.
Francisco J TinahonesDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.
Isabel Moreno-IndiasDepartment of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Instituto de Investigación Biomédica de Málaga (IBIMA), 29010 Málaga, Spain.ORCID 0000-0002-6121-151X
Instituto de Salud Carlos III · ESInstituto de Investigación Biomédica de Málaga · ES

Funding

Foro para la Investigación de la Cerveza y Estilos de Vida (FICYE)ISCIII PI18/01160, PI21/01677Miguel Servet Type I program of the Carlos III Health Institute (co-founded by the European Regional Development Fund) CP16/00163Miguel Servet Type I program of the Carlos III Health Institute (co-founded by the European Regional Development Fund) CP20/00066Network of Centers for Biomedical Research" (CIBER) of the Carlos III Health Institute (ISCIII) CB06/03/0018Sara Borrell program of the Carlos III Health Institute (co-founded by the European Regional Development Fund) CD19/00216
6 · The paper itself

Abstract

The moderate consumption of beer has been associated with positive effects on health, and these benefits are driven, in part, by the antioxidant properties of phenolic compounds found in this beverage. However, the potential impact of beer polyphenols on the human gut microbiome and their consequences are yet to be elucidated. In this study, our aim was to evaluate the effect of three different phenolic-content beers on the gut microbiome and the potential role of the induced shifts in the antioxidant capacity of beer polyphenols. In total, 20 subjects (10 healthy volunteers and 10 individuals with metabolic syndrome) were randomly assigned in a crossover design to consume each of the different beers (alcohol-free, lager or dark beer) during a 2-week intervention. Significant changes in the relative abundance of

Indexed as

antioxidantsbeergut microbiotapolyphenols

Identifiers

PMID35453381
PMCPMC9027304
OpenAlexW4221069637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.